7 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
of with Community-Acquired ... Pneumonia (CAP) ... fluoroquinolone #IDSA ... #Acquired #Pneumonia ... Management #Guidelines #pharmacology
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
steroids to treat infectious ... Acquired Pneumonia ... SCAP severe community-acquired ... #Pharmacology # ... Management #Treatment
Antibiotic treatment durations for first line antibiotics recommended by Public Health England (PHE) guidance
 • Acute
Antibiotic treatment ... acquired pneumonia ... acquired pneumonia ... and CRB65=1 7-10 ... #pharmacology #
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Toxic Megacolon, Shock ... Epidemiology: • #1 ... post-ABx, but can be community-acquired ... Ileus, Megacolon, Shock ... 10 mg/kg IV x 1
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 4–6 mL QID or 1– ... antifungals are required ... opportunistic #infections ... #HIVAIDS #pharmacology
CSF Penetration of Antimicrobials

Despite the poor CSF penetration, beta-lactams have the most research documenting successful treatment
of community-acquired ... antibiotic classes. 1 ... in clinical CNS infections ... of CNS infections ... InfectiousDiseases #Pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... Prevention and Treatment ... of Pneumocystis Pneumonia ... opportunistic #infections ... HIVAIDS #management #pharmacology